FDA Clears SPR Therapeutics’ Peripheral Nerve Stimulation Systems for Pain Management

PNS gets FDA clearance
SPR Therapeutics, Inc., a Cleveland, Ohio-based developer of neurostimulation technology for pain, announced that it has received FDA clearance for its SPRINT endura (single lead) and extensa (dual lead) Peripheral Nerve Stimulation (PNS) Systems. The SPRINT System is the only percutaneous PNS System cleared by the FDA and is the industry’s only dual lead capable […]